MarketInOut Stock Screener Log In | Sign Up

Shield Therapeutics Plc

LSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 16:01
Shield Therapeutics Plc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeLSE
Market Capitalization56.93 mln
Float409 mln
Earnings Date04/29/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.13
Reliable

Relative Strength

90 / 100
Top performer

Pre-Tax Margin

-17%
Loss-making

ROE

64.57
Exceptional

Altman Z-Score

-4.24
Deeply distressed

Business Description

Shield Therapeutics is a UK-based pharmaceutical company founded in 2008 and headquartered in Gateshead. The company brings medicines to market that address health conditions currently lacking effective treatment options. Its primary product, sold under the names Accrufer and Feraccru, is an oral iron treatment for adults that works differently from traditional iron supplements and can be used whether or not the patient has anemia.

Key Fundamentals

EPS-1.00
ROE64.57
RPS0.04
ROIC-12.31
ROA-17.30
Interest Cover-0.69
EBITDA, mln-2.24
EV / EBITDA-31.63
EV / EBIT-24.42
Revenue, mln43.68
EV / Revenue1.62

Quote Details

Last 5.33
Change -0.07 (-1.3%)
Open 5.42
Volume 545,025
Turnover 2,904,983
Average Volume 1,420,201

Financial Ratios

Pre-Tax Profit Margin-17
Current Ratio0.75
Price / Sales1.37

Financial Strength

Altman Z-Score-4.24
Piotroski F-Score 5 / 9
Beneish M-Score-3.13

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.37% 35 / 100   
1 Month -2.38% 34 / 100   
2 Months -11.61% 12 / 100   
6 Months -38.74% 4 / 100   
1 Year -17.49% 13 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog